Article Versions Notes

Papa S, Scoccia G, Serino G, Adamo FI, Jabbour JP, Caputo A, Boromei M, Filomena D, Laviola D, Maggio E, et al. Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing. Journal of Clinical Medicine. 2023; 12(21):6840. https://doi.org/10.3390/jcm12216840

Papa, Silvia, Gianmarco Scoccia, Giorgia Serino, Francesca Ileana Adamo, Jean Pierre Jabbour, Annalisa Caputo, Michela Boromei, Domenico Filomena, Domenico Laviola, Enrico Maggio, and et al. 2023. "Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing" Journal of Clinical Medicine 12, no. 21: 6840. https://doi.org/10.3390/jcm12216840

Papa, S., Scoccia, G., Serino, G., Adamo, F. I., Jabbour, J. P., Caputo, A., Boromei, M., Filomena, D., Laviola, D., Maggio, E., Manzi, G., Mihai, A., Recchioni, T., Sabusco, A., Valeri, L., Vinciullo, S., Vizza, C. D., & Badagliacca, R. (2023). Impact of Parenteral Prostanoids in Pulmonary Arterial Hypertension: The Relevance of Timing. Journal of Clinical Medicine, 12(21), 6840. https://doi.org/10.3390/jcm12216840